Navigation Links
Growing Preference for Composite Materials in Shoulder Fixation and Knee Ligament Reconstruction Markets
Date:1/13/2009

Composite segments of shoulder fixation and knee ligament reconstruction markets to grow at rates above 50% and 20%, respectively, from 2008 to 2013, according to Millennium Research Group

WALTHAM, Mass., Jan. 13 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Orthopedic Soft Tissue Solutions 2009 report, there is a growing preference for the use of composite materials in both shoulder fixation and knee ligament reconstruction. Each composite device market will see impressive compound annual growth rates from 2008 to 2013 of over 50% and over 20%, respectively.

Over the next five years, physicians will increasingly shift away from using polymer suture anchors to composite suture anchors in shoulder fixation. Suture anchors composed of composite materials are often embedded with various biocompatible and bioactive materials, such as hydroxyapatite and tricalcium phosphate. In 2008, many companies, including market leader Arthrex, launched composite suture anchors to compete with DePuy Mitek -- the only company to actively market a composite suture anchor in 2007. Over the next 5 years, several more composite suture anchor products are expected to enter the market.

"In the resorbable bone-patellar tendon-bone (BTB) fixation device segment, there is also a growing shift away from polymer-based materials towards composite devices -- in this case interference screws," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "Composite materials not only resorb into the body, but promote bone growth too. In the coming years, new products, such as the BioComposite Interference Screw from Arthrex, will stimulate additional interest in the market as manufacturers promote the use of composite materials. This interest is expected to translate into more than 20% annual growth in the BTB composite interference screw segment of the knee ligament reconstruction market over the next five years."

MRG's US Markets for Orthopedic Soft Tissue Solutions 2009 report provides coverage of key industry competitors including Arthrex, ArthroCare, Biomet Sports Medicine, ConMed Linvatec, DePuy Mitek, Genzyme Biosurgery, Joint Restoration Foundation, LifeNet Health, Musculoskeletal Transplant Foundation, and Smith & Nephew.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Growing Shortage of Gastroenterologists to Affect Screening Capacity for #2 Cancer Killer
2. Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
3. Veteran Rehab Specialist, Ted ONeill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania
4. Launch of New Independent Aging Company Will Address the Needs of the Growing Senior Population
5. Colorectal Cancer Racial Gap Still Growing
6. Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden
7. NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals
8. CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information
9. Americas 5000 Fastest-Growing Private Companies Revealed
10. Happiness Spreads Through African Villages Thanks to Growing Contributions from Long Term Care Insurance Professionals
11. NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: